Cost Effectiveness of Personalized Therapy for First-Line Treatment of Stage IV and Recurrent Incurable Adenocarcinoma of the Lung

Title
Cost Effectiveness of Personalized Therapy for First-Line Treatment of Stage IV and Recurrent Incurable Adenocarcinoma of the Lung
Authors
Keywords
-
Journal
Journal of Oncology Practice
Volume 8, Issue 5, Pages 267-274
Publisher
American Society of Clinical Oncology (ASCO)
Online
2012-09-18
DOI
10.1200/jop.2011.000502

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More